{"transactions":[{"id":3018082,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-08-21","kind":"sale","acquired":false,"shares":75000,"price":0.38,"value":28500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":1405433,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018081,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-08-20","kind":"sale","acquired":false,"shares":75000,"price":0.27,"value":20250.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":1480433,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018080,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-08-19","kind":"sale","acquired":false,"shares":50000,"price":0.3,"value":15000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":1555433,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018079,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-08-18","kind":"sale","acquired":false,"shares":50000,"price":0.34,"value":17000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":1605433,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018078,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-08-14","kind":"sale","acquired":false,"shares":50000,"price":0.31,"value":15500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":1655433,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018077,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-08-03","kind":"sale","acquired":false,"shares":70000,"price":0.32,"value":22400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":1705433,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018076,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-07-31","kind":"sale","acquired":false,"shares":5000,"price":0.34,"value":1700.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":1775433,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018075,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-07-30","kind":"sale","acquired":false,"shares":25000,"price":0.32,"value":8000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":1780433,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018074,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-07-21","kind":"sale","acquired":false,"shares":50000,"price":0.45,"value":22500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":1805433,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018073,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-07-20","kind":"sale","acquired":false,"shares":150000,"price":0.43,"value":64500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":1855433,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018072,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-07-17","kind":"sale","acquired":false,"shares":50000,"price":0.38,"value":19000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":2005433,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018071,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-07-16","kind":"sale","acquired":false,"shares":50000,"price":0.38,"value":19000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":2055433,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018070,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-07-06","kind":"sale","acquired":false,"shares":6450,"price":0.39,"value":2515.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":2105433,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018069,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-07-02","kind":"sale","acquired":false,"shares":57000,"price":0.4,"value":22800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":2111883,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018068,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-07-01","kind":"sale","acquired":false,"shares":45000,"price":0.38,"value":17100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":2168883,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018067,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-06-29","kind":"sale","acquired":false,"shares":68094,"price":0.39,"value":26556.66,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":2213883,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018066,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-06-26","kind":"sale","acquired":false,"shares":80000,"price":0.38,"value":30400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":2281977,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018065,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-06-25","kind":"sale","acquired":false,"shares":100000,"price":0.4,"value":40000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":2361977,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018064,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-06-24","kind":"sale","acquired":false,"shares":55530,"price":0.42,"value":23322.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":2461977,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018063,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-06-23","kind":"sale","acquired":false,"shares":80000,"price":0.43,"value":34400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":2517507,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018062,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-06-22","kind":"sale","acquired":false,"shares":63186,"price":0.46,"value":29065.56,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":2597507,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018061,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-06-19","kind":"sale","acquired":false,"shares":80000,"price":0.46,"value":36800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":2660693,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018060,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-06-18","kind":"sale","acquired":false,"shares":61640,"price":0.45,"value":27738.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":2740693,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018059,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-06-17","kind":"sale","acquired":false,"shares":203100,"price":0.48,"value":97488.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":2802333,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018058,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-06-16","kind":"sale","acquired":false,"shares":150000,"price":0.43,"value":64500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":3005433,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018057,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-06-15","kind":"sale","acquired":false,"shares":100000,"price":0.42,"value":42000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":3155433,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018056,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-06-11","kind":"sale","acquired":false,"shares":100000,"price":0.39,"value":39000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":3255433,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3118080,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-06-08T17:43:40.000Z","date":"2020-06-03","kind":"sale","acquired":false,"shares":1683,"price":0.31,"value":521.73,"ownership":{"direct":true},"balance_after":3355433,"source":{"system":"sec-edgar","filing":"0001493152-20-010731","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220010731/ownership.xml","form_type":"4"}},{"id":3118079,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-06-08T17:43:40.000Z","date":"2020-06-03","kind":"sale","acquired":false,"shares":3900,"price":0.31,"value":1209.0,"ownership":{"direct":true},"balance_after":3357116,"source":{"system":"sec-edgar","filing":"0001493152-20-010731","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220010731/ownership.xml","form_type":"4"}},{"id":3118078,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-06-08T17:43:40.000Z","date":"2020-06-02","kind":"sale","acquired":false,"shares":220000,"price":0.33,"value":72600.0,"ownership":{"direct":true},"balance_after":3361016,"source":{"system":"sec-edgar","filing":"0001493152-20-010731","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220010731/ownership.xml","form_type":"4"}},{"id":3148394,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-14T13:46:31.000Z","date":"2019-06-07","kind":"sale","acquired":false,"shares":400668,"price":0.87,"value":348581.16,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"400,668 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.87. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 5."}],"balance_after":3865161,"source":{"system":"sec-edgar","filing":"0001493152-20-008636","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220008636/ownership.xml","form_type":"5"}},{"id":3148393,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-14T13:45:40.000Z","date":"2019-06-07","kind":"sale","acquired":false,"shares":684813,"price":0.67,"value":458824.71,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"684,813 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.67. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"684,813 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.67. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":3581016,"source":{"system":"sec-edgar","filing":"0001493152-20-008635","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220008635/ownership.xml","form_type":"4"}},{"id":3511327,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-05-24T21:30:11.000Z","date":"2019-05-21","kind":"other","acquired":false,"shares":177740,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Biodyne Holding, S.A., an entity organized under the laws of Switzerland, transferred an aggregate of 177,740 shares to two of its minority shareholders in exchange for the forfeiture of thier equity ownership in Biodyne Holding, S.A."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Biodyne Holding, S.A., an entity organized under the laws of Switzerland, transferred an aggregate of 177,740 shares to two of its minority shareholders in exchange for the forfeiture of thier equity ownership in Biodyne Holding, S.A."}],"balance_after":4265829,"source":{"system":"sec-edgar","filing":"0001493152-19-008257","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315219008257/ownership.xml","form_type":"4"}}]}